▲ Peaking
Business
FDA approves Otsuka’s ADHD drug Simtriyo, teeing up its ‘next major CNS launch’
3sources
3articles
1velocity
+0%since first seen
just nowfirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (3)
- FDA Approves Simtriyo Pharmaceutical Executive · 9h ago
- Otsuka’s ADHD approval opens up new drug class with $615M opportunity BioSpace · 9h ago
- FDA approves Otsuka’s ADHD drug Simtriyo, teeing up its ‘next major CNS launch’ Fierce Pharma · 9h ago
Related trends
▲ Peaking
Business
PSA: T-Mobile is down, iPhones showing ‘SOS’ mode
▲ Peaking
Business
US Department of Energy includes Arkansas, Oklahoma in emergency order amid extreme heat
▲ Peaking
Business
Nvidia’s Huang heads to Capitol Hill for AI talks
▲ Peaking
Business
Biggest US Grid to Launch Emergency Power Auction for AI Boom
▲ Peaking
Business
JetBlue reveals name for new first class, brings basic fares to more cabins
▲ Peaking
Business